Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.
about
The Dichotomy of Tumor Exosomes (TEX) in Cancer Immunity: Is It All in the ConTEXt?Anatomy of a discovery: m1 and m2 macrophagesPro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsOrigin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cellsDexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549)Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression.Mechanisms and applications of interleukins in cancer immunotherapy.Methylcholanthrene-Induced Sarcomas Develop Independently from NOX2-Derived ROS.Immune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan and polyethylene glycolCancer-testis antigens and immunotherapy in the light of cancer complexity.Immunological landscape and immunotherapy of hepatocellular carcinoma.Coexpressed Catalase Protects Chimeric Antigen Receptor-Redirected T Cells as well as Bystander Cells from Oxidative Stress-Induced Loss of Antitumor Activity.Immunophenotype of neutrophils in oral squamous cell carcinoma patients.Insulin-like growth factor-1 endues monocytes with immune suppressive ability to inhibit inflammation in the intestine.Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade.Targeting neoantigens to augment antitumour immunity.Immunity Enhancement in Immunocompromised Gastrointestinal Cancer Patients with Allogeneic Umbilical Cord Blood Mononuclear Cell Transfusion.PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis.A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment.Therapeutic cancer vaccines.Impact of the Tumor Microenvironment on the Expression of Inflammatory Mediators in Cancer Cells.
P2860
Q26773307-AA929B52-31C0-4BE2-82A5-D373C0CF95EAQ26830065-604C96F7-44B4-4F09-AC37-EDBC62B1353CQ28076161-B8DE0E6C-7EE3-4422-973D-73CCA6BDD03AQ28081922-7E568145-8488-4ABC-9194-17171AA0CCABQ28829762-BB473088-F03E-45C2-9E1F-3A703132A0D2Q33578254-7686A77D-BF75-4CC3-8130-F6ECEA9E3D84Q33694988-F73614C6-A5F0-4E11-88E4-8428DC1FDBA2Q34458290-44EE4415-C6EA-4444-BEB0-B325E09F6990Q35663908-B179D5A4-FB3A-4A00-BD5D-BFBFEAB50880Q36427935-7B9BDAA6-52F7-45E1-B0FB-35F623D1BD3AQ38435410-1A7189B4-CBCE-4AE0-A1FA-BB0DACA46B9DQ38611895-66AF0BD7-E036-437A-BCA7-AC5C3E1B1397Q38811497-E80250A3-7636-48BE-A244-636EC2B4FA4EQ38859422-6176EFFB-6EED-491F-ACA0-E2BE775951AEQ38920040-0AE09705-63EB-43E4-98C5-FE0B60ECF518Q38998454-99D07092-EBDD-43FE-B0BE-7E6E75A1B956Q39149196-6CDD1A46-29E4-488B-9FB6-B27AA0703AA0Q42281037-B445C1A2-490D-4553-B9ED-0B8975CB4696Q47098690-21F3BB6E-8FB1-40F4-93E0-5E0465CADB6BQ47275348-E7D6C786-F89B-495E-9D71-78FE995A574BQ50988785-2D3ACF62-3BBD-455F-873F-65584B07645FQ51470672-8712874F-68B0-4913-948A-885933036C79
P2860
Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tumour-induced immune suppress ...... eased by myelomonocytic cells.
@en
type
label
Tumour-induced immune suppress ...... eased by myelomonocytic cells.
@en
prefLabel
Tumour-induced immune suppress ...... eased by myelomonocytic cells.
@en
P2860
P356
P1476
Tumour-induced immune suppress ...... leased by myelomonocytic cells
@en
P2093
R Kiessling
P2860
P304
P356
10.1111/JOIM.12229
P407
P50
P577
2014-03-24T00:00:00Z